Concepedia

Ildiko Lingvay

IL

125

Publications

23.3K

Citations

61

H-Index

2007

Active since

Affiliations

The University of Texas Southwestern Medical Center(Current)

Novo Nordisk (Denmark)

Southwestern Medical Center

Harvard University

Ildiko Lingvay is an author at The University of Texas Southwestern Medical Center specializing in medicine, diabetes, and pharmacology.

ORCID

Top concepts

Publications per year

2007–2025

125

Publications

125

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John Wilding, Rachel L. Batterham, Salvatore Calanna et al. · New England Journal of Medicine · 2021 · 3.9K citations

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun et al. · New England Journal of Medicine · 2023 · 2.1K citations · Full text

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark et al. · New England Journal of Medicine · 2019 · 1.8K citations · Full text

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

Melanie J. Davies, Louise Færch, Ole Kleist Jeppesen et al. · The Lancet · 2021 · 1.2K citations

, , +6

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

Domenica Rubino, Niclas Abrahamsson, Melanie J. Davies et al. · JAMA · 2021 · 1.1K citations · Full text

Rows per page

1–5 of 125